Is SCHD a Good ETF to Buy?
With around $65.7 billion in net assets, Schwab’s US Dividend…
Sell
26
CBT Quote, Financials, Valuation and Earnings
Last price:
$88.81
Seasonality move
:
6.74%
Day range:
$88.66 - $90.32
52-week range:
$70.63 - $117.46
Dividend yield:
1.91%
P/E ratio:
13.16x
P/S ratio:
1.24x
P/B ratio:
3.39x
Volume:
246.1K
Avg. volume:
381.7K
1-year change:
14.48%
Market cap:
$4.8B
Revenue:
$4B
EPS (TTM):
$6.74
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $2.6B | $3.4B | $4.3B | $3.9B | $4B | |
| Revenue Growth (YoY) | -21.67% | 30.41% | 26.75% | -9.03% | 1.6% | |
| Cost of Revenues | $2.1B | $2.6B | $3.4B | $3.1B | $3B | |
| Gross Profit | $500M | $799M | $885M | $839M | $960M | |
| Gross Profit Margin | 19.13% | 23.44% | 20.48% | 21.34% | 24.04% | |
| R&D Expenses | $57M | $56M | $55M | $57M | $63M | |
| Selling, General & Admin | $292M | $289M | $258M | $253M | $283M | |
| Other Inc / (Exp) | -$138M | -$7M | -$192M | -$19M | -$36M | |
| Operating Expenses | $349M | $345M | $313M | $310M | $346M | |
| Operating Income | $151M | $454M | $572M | $529M | $614M | |
| Net Interest Expenses | $45M | $41M | $45M | $59M | $49M | |
| EBT. Incl. Unusual Items | -$33M | $406M | $335M | $451M | $529M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $191M | $123M | $102M | -$28M | $111M | |
| Net Income to Company | -$221M | $286M | $243M | $484M | $424M | |
| Minority Interest in Earnings | -$17M | -$36M | -$34M | -$39M | -$44M | |
| Net Income to Common Excl Extra Items | -$238M | $250M | $209M | $445M | $380M | |
| Basic EPS (Cont. Ops) | -$4.21 | $4.35 | $3.65 | $7.79 | $6.79 | |
| Diluted EPS (Cont. Ops) | -$4.21 | $4.34 | $3.62 | $7.73 | $6.72 | |
| Weighted Average Basic Share | $56.6M | $56.7M | $56.5M | $56.1M | $55.1M | |
| Weighted Average Diluted Share | $56.6M | $56.8M | $56.9M | $56.5M | $55.7M | |
| EBITDA | $178M | $615M | $537M | $685M | $761M | |
| EBIT | $20M | $455M | $391M | $541M | $610M | |
| Revenue (Reported) | $2.6B | $3.4B | $4.3B | $3.9B | $4B | |
| Operating Income (Reported) | $151M | $454M | $572M | $529M | $614M | |
| Operating Income (Adjusted) | $20M | $455M | $391M | $541M | $610M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $659M | $904M | $1.1B | $965M | $1B | |
| Revenue Growth (YoY) | -20.31% | 37.18% | 23.01% | -13.22% | 3.73% | |
| Cost of Revenues | $522M | $726M | $892M | $740M | $761M | |
| Gross Profit | $137M | $178M | $220M | $225M | $240M | |
| Gross Profit Margin | 20.79% | 19.69% | 19.78% | 23.32% | 23.98% | |
| R&D Expenses | $16M | $15M | $14M | $14M | $17M | |
| Selling, General & Admin | $62M | $89M | $62M | $69M | $73M | |
| Other Inc / (Exp) | -$131M | $2M | -$1M | -$3M | -$3M | |
| Operating Expenses | $78M | $104M | $76M | $83M | $90M | |
| Operating Income | $59M | $74M | $144M | $142M | $150M | |
| Net Interest Expenses | $11M | $10M | $14M | $12M | $12M | |
| EBT. Incl. Unusual Items | -$84M | $66M | $129M | $127M | $135M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $182M | $30M | $29M | -$118M | -$10M | |
| Net Income to Company | -$265M | $36M | $103M | $246M | $146M | |
| Minority Interest in Earnings | -$7M | -$7M | -$9M | -$12M | -$9M | |
| Net Income to Common Excl Extra Items | -$272M | $29M | $94M | $234M | $137M | |
| Basic EPS (Cont. Ops) | -$4.82 | $0.51 | $1.67 | $4.24 | $2.52 | |
| Diluted EPS (Cont. Ops) | -$4.82 | $0.50 | $1.64 | $4.10 | $2.43 | |
| Weighted Average Basic Share | $56.3M | $56.7M | $56.5M | $55.8M | $54.5M | |
| Weighted Average Diluted Share | $56.3M | $56.8M | $56.9M | $55.9M | $55.4M | |
| EBITDA | -$31M | $121M | $182M | $185M | $191M | |
| EBIT | -$72M | $78M | $147M | $148M | $154M | |
| Revenue (Reported) | $659M | $904M | $1.1B | $965M | $1B | |
| Operating Income (Reported) | $59M | $74M | $144M | $142M | $150M | |
| Operating Income (Adjusted) | -$72M | $78M | $147M | $148M | $154M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $2.6B | $3.4B | $4.3B | $3.9B | $4B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $2.1B | $2.6B | $3.4B | $3.1B | $3B | |
| Gross Profit | $500M | $799M | $885M | $839M | $960M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $57M | $56M | $55M | $57M | $63M | |
| Selling, General & Admin | $292M | $289M | $258M | $253M | $283M | |
| Other Inc / (Exp) | -$138M | -$7M | -$192M | -$19M | -$36M | |
| Operating Expenses | $349M | $345M | $313M | $310M | $346M | |
| Operating Income | $151M | $454M | $572M | $529M | $614M | |
| Net Interest Expenses | $45M | $41M | $45M | $59M | $49M | |
| EBT. Incl. Unusual Items | -$33M | $406M | $335M | $451M | $529M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $191M | $123M | $102M | -$28M | $111M | |
| Net Income to Company | -$221M | $286M | $243M | $484M | $424M | |
| Minority Interest in Earnings | -$17M | -$36M | -$34M | -$39M | -$44M | |
| Net Income to Common Excl Extra Items | -$238M | $250M | $209M | $445M | $380M | |
| Basic EPS (Cont. Ops) | -$4.24 | $4.36 | $3.66 | $7.93 | $6.86 | |
| Diluted EPS (Cont. Ops) | -$4.25 | $4.34 | $3.60 | $7.75 | $6.74 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | $178M | $615M | $537M | $685M | $761M | |
| EBIT | $20M | $455M | $391M | $541M | $610M | |
| Revenue (Reported) | $2.6B | $3.4B | $4.3B | $3.9B | $4B | |
| Operating Income (Reported) | $151M | $454M | $572M | $529M | $614M | |
| Operating Income (Adjusted) | $20M | $455M | $391M | $541M | $610M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $3.4B | $4.3B | $3.9B | $4B | -- | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $2.6B | $3.4B | $3.1B | $3B | -- | |
| Gross Profit | $799M | $885M | $839M | $960M | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $56M | $55M | $57M | $63M | -- | |
| Selling, General & Admin | $289M | $258M | $253M | $283M | -- | |
| Other Inc / (Exp) | -$7M | -$192M | -$19M | -$36M | -- | |
| Operating Expenses | $345M | $313M | $310M | $346M | -- | |
| Operating Income | $454M | $572M | $529M | $614M | -- | |
| Net Interest Expenses | $41M | $45M | $59M | $49M | -- | |
| EBT. Incl. Unusual Items | $406M | $335M | $451M | $529M | -- | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $123M | $102M | -$28M | $111M | -- | |
| Net Income to Company | $286M | $243M | $484M | $424M | -- | |
| Minority Interest in Earnings | -$36M | -$34M | -$39M | -$44M | -- | |
| Net Income to Common Excl Extra Items | $250M | $209M | $445M | $380M | -- | |
| Basic EPS (Cont. Ops) | $4.36 | $3.66 | $7.93 | $6.86 | -- | |
| Diluted EPS (Cont. Ops) | $4.34 | $3.60 | $7.75 | $6.74 | -- | |
| Weighted Average Basic Share | $226.5M | $226.2M | $224.5M | $220.3M | -- | |
| Weighted Average Diluted Share | $227.1M | $227.6M | $225.9M | $222.7M | -- | |
| EBITDA | $615M | $537M | $685M | $761M | -- | |
| EBIT | $455M | $391M | $541M | $610M | -- | |
| Revenue (Reported) | $3.4B | $4.3B | $3.9B | $4B | -- | |
| Operating Income (Reported) | $454M | $572M | $529M | $614M | -- | |
| Operating Income (Adjusted) | $455M | $391M | $541M | $610M | -- | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $151M | $168M | $206M | $238M | $223M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | $418M | $645M | $836M | $695M | $733M | |
| Inventory | $359M | $523M | $664M | $585M | $552M | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | $50M | $89M | $114M | $108M | $97M | |
| Total Current Assets | $978M | $1.4B | $1.8B | $1.6B | $1.6B | |
| Property Plant And Equipment | $1.3B | $1.4B | $1.3B | $1.4B | $1.5B | |
| Long-Term Investments | $39M | $40M | $20M | $20M | $23M | |
| Goodwill | $134M | $140M | $129M | $134M | $133M | |
| Other Intangibles | $103M | $100M | $63M | $60M | $53M | |
| Other Long-Term Assets | $160M | $172M | $178M | $172M | $172M | |
| Total Assets | $2.8B | $3.3B | $3.5B | $3.6B | $3.7B | |
| Accounts Payable | $316M | $480M | $533M | $438M | $495M | |
| Accrued Expenses | $126M | $112M | $108M | $107M | $107M | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | $8M | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $529M | $1.1B | $1.1B | $822M | $772M | |
| Long-Term Debt | $1.1B | $717M | $1.1B | $1.1B | $1.1B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $2B | $2.2B | $2.5B | $2.2B | $2.1B | |
| Common Stock | $57M | $57M | $56M | $55M | $54M | |
| Other Common Equity Adj | -$351M | -$289M | -$439M | -$362M | -$360M | |
| Common Equity | $691M | $947M | $898M | $1.3B | $1.4B | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | $123M | $143M | $134M | $143M | $165M | |
| Total Equity | $814M | $1.1B | $1B | $1.4B | $1.6B | |
| Total Liabilities and Equity | $2.8B | $3.3B | $3.5B | $3.6B | $3.7B | |
| Cash and Short Terms | $151M | $168M | $206M | $238M | $223M | |
| Total Debt | $1.1B | $1.2B | $1.4B | $1.3B | $1.1B | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $151M | $168M | $206M | $238M | $223M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | $418M | $645M | $836M | $695M | $733M | |
| Inventory | $359M | $523M | $664M | $585M | $552M | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | $50M | $89M | $114M | $108M | $97M | |
| Total Current Assets | $978M | $1.4B | $1.8B | $1.6B | $1.6B | |
| Property Plant And Equipment | $1.3B | $1.4B | $1.3B | $1.4B | $1.5B | |
| Long-Term Investments | $39M | $40M | $20M | $20M | $23M | |
| Goodwill | $134M | $140M | $129M | $134M | $133M | |
| Other Intangibles | $103M | $100M | $63M | $60M | $53M | |
| Other Long-Term Assets | $160M | $172M | $178M | $172M | $172M | |
| Total Assets | $2.8B | $3.3B | $3.5B | $3.6B | $3.7B | |
| Accounts Payable | $316M | $480M | $533M | $438M | $495M | |
| Accrued Expenses | $126M | $112M | $108M | $107M | $107M | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | $8M | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $529M | $1.1B | $1.1B | $822M | $772M | |
| Long-Term Debt | $1.1B | $717M | $1.1B | $1.1B | $1.1B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $2B | $2.2B | $2.5B | $2.2B | $2.1B | |
| Common Stock | $57M | $57M | $56M | $55M | $54M | |
| Other Common Equity Adj | -$351M | -$289M | -$439M | -$362M | -$360M | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | $123M | $143M | $134M | $143M | $165M | |
| Total Equity | $814M | $1.1B | $1B | $1.4B | $1.6B | |
| Total Liabilities and Equity | $2.8B | $3.3B | $3.5B | $3.6B | $3.7B | |
| Cash and Short Terms | $151M | $168M | $206M | $238M | $223M | |
| Total Debt | $1.1B | $1.2B | $1.4B | $1.3B | $1.1B | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$221M | $286M | $243M | $484M | $424M | |
| Depreciation & Amoritzation | $158M | $160M | $146M | $144M | $151M | |
| Stock-Based Compensation | $9M | $21M | $23M | $20M | $25M | |
| Change in Accounts Receivable | $126M | -$215M | -$287M | $153M | -$26M | |
| Change in Inventories | $114M | -$174M | -$259M | $96M | $41M | |
| Cash From Operations | $377M | $257M | $100M | $595M | $692M | |
| Capital Expenditures | $200M | $195M | $211M | $244M | $241M | |
| Cash Acquisitions | -$92M | -- | $70M | $6M | -- | |
| Cash From Investing | -$288M | -$186M | -$118M | -$214M | -$235M | |
| Dividends Paid (Ex Special Dividend) | -$80M | -$80M | -$84M | -$88M | -$93M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $444M | $258M | $670M | $108M | $15M | |
| Long-Term Debt Repaid | -$410M | -$222M | -$372M | -$287M | -$158M | |
| Repurchase of Common Stock | -$44M | -$3M | -$53M | -$98M | -$172M | |
| Other Financing Activities | -$26M | -$19M | -$22M | -$42M | -$27M | |
| Cash From Financing | -$132M | -$60M | $145M | -$403M | -$415M | |
| Beginning Cash (CF) | $169M | $151M | $170M | $206M | $238M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$43M | $11M | $127M | -$22M | $42M | |
| Ending Cash (CF) | $151M | $170M | $206M | $238M | $223M | |
| Levered Free Cash Flow | $177M | $62M | -$111M | $351M | $451M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$265M | $36M | $103M | $246M | $146M | |
| Depreciation & Amoritzation | $41M | $43M | $35M | $37M | $37M | |
| Stock-Based Compensation | $4M | $5M | $6M | $5M | $6M | |
| Change in Accounts Receivable | -$46M | -$17M | -$1M | -$20M | $21M | |
| Change in Inventories | $40M | -$49M | -$28M | -$4M | $14M | |
| Cash From Operations | $99M | $100M | $105M | $138M | $204M | |
| Capital Expenditures | $38M | $80M | $90M | $78M | $92M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$36M | -$76M | -$87M | -$75M | -$89M | |
| Dividends Paid (Ex Special Dividend) | -$20M | -$20M | -$21M | -$23M | -$24M | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | $62M | $57M | $5M | $1M | |
| Long-Term Debt Repaid | -$76M | -$55M | -$15M | $37M | -$5M | |
| Repurchase of Common Stock | -- | -$1M | -$5M | -$50M | -$66M | |
| Other Financing Activities | -- | $1M | -- | -$1M | -- | |
| Cash From Financing | -$95M | -$12M | $16M | -$32M | -$89M | |
| Beginning Cash (CF) | $162M | $173M | $214M | $220M | $197M | |
| Foreign Exchange Rate Adjustment | $21M | -$15M | -$42M | -$13M | -- | |
| Additions / Reductions | -$32M | $12M | $34M | $31M | $26M | |
| Ending Cash (CF) | $151M | $170M | $206M | $238M | $223M | |
| Levered Free Cash Flow | $61M | $20M | $15M | $60M | $112M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$221M | $286M | $243M | $484M | $424M | |
| Depreciation & Amoritzation | $158M | $160M | $146M | $144M | $151M | |
| Stock-Based Compensation | $9M | $21M | $23M | $20M | $25M | |
| Change in Accounts Receivable | $126M | -$215M | -$287M | $153M | -$26M | |
| Change in Inventories | $114M | -$174M | -$259M | $96M | $41M | |
| Cash From Operations | $377M | $257M | $100M | $595M | $692M | |
| Capital Expenditures | $200M | $195M | $211M | $244M | $241M | |
| Cash Acquisitions | -$92M | -- | $70M | $6M | -- | |
| Cash From Investing | -$288M | -$186M | -$118M | -$214M | -$235M | |
| Dividends Paid (Ex Special Dividend) | -$80M | -$80M | -$84M | -$88M | -$93M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $444M | $258M | $670M | $108M | $15M | |
| Long-Term Debt Repaid | -$410M | -$222M | -$372M | -$287M | -$158M | |
| Repurchase of Common Stock | -$44M | -$3M | -$53M | -$98M | -$172M | |
| Other Financing Activities | -$26M | -$19M | -$22M | -$42M | -$27M | |
| Cash From Financing | -$132M | -$60M | $145M | -$403M | -$415M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$43M | $11M | $127M | -$22M | $42M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | $177M | $62M | -$111M | $351M | $451M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $286M | $243M | $484M | $424M | -- | |
| Depreciation & Amoritzation | $160M | $146M | $144M | $151M | -- | |
| Stock-Based Compensation | $21M | $23M | $20M | $25M | -- | |
| Change in Accounts Receivable | -$215M | -$287M | $153M | -$26M | -- | |
| Change in Inventories | -$174M | -$259M | $96M | $41M | -- | |
| Cash From Operations | $257M | $100M | $595M | $692M | -- | |
| Capital Expenditures | $195M | $211M | $244M | $241M | -- | |
| Cash Acquisitions | -- | $70M | $6M | -- | -- | |
| Cash From Investing | -$186M | -$118M | -$214M | -$235M | -- | |
| Dividends Paid (Ex Special Dividend) | -$80M | -$84M | -$88M | -$93M | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $258M | $670M | $108M | $15M | -- | |
| Long-Term Debt Repaid | -$222M | -$372M | -$287M | -$158M | -- | |
| Repurchase of Common Stock | -$3M | -$53M | -$98M | -$172M | -- | |
| Other Financing Activities | -$19M | -$22M | -$42M | -$27M | -- | |
| Cash From Financing | -$60M | $145M | -$403M | -$415M | -- | |
| Beginning Cash (CF) | $621M | $779M | $821M | $885M | -- | |
| Foreign Exchange Rate Adjustment | $8M | -$91M | $54M | -$57M | -- | |
| Additions / Reductions | $11M | $127M | -$22M | $42M | -- | |
| Ending Cash (CF) | $640M | $815M | $853M | $870M | -- | |
| Levered Free Cash Flow | $62M | -$111M | $351M | $451M | -- | |
Get CBT Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
CBT
Sector
P/E ratio
13.16x
16.23x
PEG ratio
0.21x
0.00x
P/B ratio
3.39x
1.26x
Price / LTM sales
1.24x
1.44x
Growth Metrics
CBT
Sector
Revenue growth
3.73%
0.41%
Earnings growth
-40.73%
-0.36%
Revenue (5-year growth)
3.66%
3.81%
Earnings forecast
$1.78
$0.06
Profitability
CBT
Sector
Profitability FY 2024
$960M
$235.7K
Return on invested capital
14.05%
2.13%
Return on assets
10.43%
1.46%
Return on equity
25.42%
3.06%
Earnings Date
Last Earnings Date
Nov
4
Next Earnings Date
Feb
5
Estimated Next Earnings Date
Feb
3
Balance Sheet
CBT
Sector
Total cash
$223M
$2.9M
Short term investments
--
$482.6K
Total assets
$3.7B
$26.8M
Long term debt
$1.1B
$49.9M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is NAIL a Good ETF to Buy?
If you’re thinking about buying the NAIL ETF, this article…
3 High Dividend Dow Jones Stocks
Thanks to surging stock prices over the past two years,…
Stock Ideas
Sell
42
Is AAPL Stock a Buy?
Market Cap: $3.7T
P/E Ratio: 40x
Buy
59
Is NVDA Stock a Buy?
Market Cap: $3.7T
P/E Ratio: 125x
Sell
46
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 36x
Alerts
Sell
50
NARI alert for Jan 7
Inari Medical [NARI] is up 22.25% over the past day.
Buy
70
PDEX alert for Jan 7
Pro-Dex [PDEX] is down 10.89% over the past day.
Buy
52
ALCO alert for Jan 7
Alico [ALCO] is down 3.89% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
